LYLLANA is a Transdermal Patch, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Amneal Pharmaceuticals Llc. The primary component is Estradiol.
Product ID | 65162-149_17bf7bfa-b260-46cb-9a81-4ce798477a5b |
NDC | 65162-149 |
Product Type | Human Prescription Drug |
Proprietary Name | LYLLANA |
Generic Name | Estradiol |
Dosage Form | Patch, Extended Release |
Route of Administration | TRANSDERMAL |
Marketing Start Date | 2020-09-30 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA211396 |
Labeler Name | Amneal Pharmaceuticals LLC |
Substance Name | ESTRADIOL |
Active Ingredient Strength | 0 mg/d |
Pharm Classes | Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2020-09-30 |
NDC Exclude Flag | N |
Sample Package? | N |
NDC | Brand Name | Generic Name |
---|---|---|
65162-126 | LYLLANA | LYLLANA |
65162-149 | LYLLANA | LYLLANA |
65162-150 | LYLLANA | LYLLANA |
65162-228 | LYLLANA | LYLLANA |
65162-148 | LYLLANA | LYLLANA |
0023-5885 | Alora | Estradiol |
0023-5886 | Alora | Estradiol |
0023-5887 | Alora | Estradiol |
0023-5888 | Alora | Estradiol |
0037-4801 | ELESTRIN | ESTRADIOL |
0037-4802 | ELESTRIN | ESTRADIOL |
0013-2150 | Estring | estradiol |
0078-0343 | Vivelle-Dot | estradiol |
0078-0344 | Vivelle-Dot | estradiol |
0078-0345 | Vivelle-Dot | estradiol |
0078-0346 | Vivelle-Dot | estradiol |
0078-0365 | Vivelle-Dot | estradiol |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
LYLLANA 88769420 not registered Live/Pending |
Amneal Pharmaceuticals LLC 2020-01-22 |